Solasia Pharma K.K.

¥23.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4597Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (21.96%)
Div yield —
ROE (65.98%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.20
PE TTM —
TSR TTM (28.12%)
Mkt cap ¥6.279B
ROIC (38.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
9.40%
(72.44%)
Hold 10|6|5|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.33
0.35
0.37
0.36
27.30%
22.96%
30.36%
15.84%
Revenue¥M
393.5
400.4
414.4
428.5
16.66%
12.60%
15.79%
14.11%
Peers (US$39.87M)
Cap (US$)
PE
39.77M
37.01x
Capital
TTM
5Y
10Y
Leveragex
0.125
(0.037)
(0.038)
EBIT/Intx
0.497
1.599
1.146
Own earn%
77.73
66.21
75.83
Sh yield%
31.26
13.27
11.74
Owners
Insiders/Inst%
0.28
82.93
Short interest%
3.30
SBC / revenue%
0.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
14–19
$1 testx
—
Incr. ROIC%
7